CytomX Therapeutics Inc. (CTMX) dipped -6.22% or -0.71 to $10.7. It is approximately 286113 shares traded, which is 35.63% compare to the average total volume 802986. The market cap of CTMX is $482.69 million. The year to date change is -33.18%. The 52 week price range is from $9.38 to $30.73. Price of CTMX have changed 6.84% during last week. It have changed 13.31% over last month, -32.16% over last 3 months, -32.04% over last 6 months and -59.87% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 13.75. It is 28.50% above current price. The 200-day Moving Averages for CTMX is 17.64. It is 64.86% above current price. The 52-week High is 30.73. It is 187.20% from the current price. The 52-week Low is 9.38. It is -12.34% from current price.
There are some statistics of CTMX. It is has market cap $482.69 million. The share outstanding is 45.11 million. The average volume is 802986. The percent of top 15 Institution holding is 133.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -85.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -20.20%.